Evidence map›Paper›PMID 20225950›Full record

ReviewThe Journal of infectious diseases2010

Public health rationale for rapid nucleic acid or p24 antigen tests for HIV.

Christopher D Pilcher, Katerina A Christopoulos, Matthew Golden

Open access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in The Journal of infectious diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Using HIV Sequence and Epidemiologic Data to Assess the Effect of Self-referral Testing for Acute HIV Infection on Incident Diagnoses in San Diego, California.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Christopher D PilcherHIV/AIDS Division, University of California, San Francisco, San Francisco, CA 94110, USA. cpilcher@php.ucsf.edu
Katerina A Christopoulos
Matthew Golden
University of California, San Francisco · USHarborview Medical Center · US

Funding

Targeting Acute HIVR01MH068686 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PILCHER, CHRISTOPHER D · 2003 to 2007
$1.6M
NIMH NIH HHS R01 MH068686
6 · The paper itself

Abstract

Rapid diagnostic tests that might be capable of detecting human immunodeficiency virus (HIV) antigens or nucleic acids represent the possibility of merging 2 key advancements in HIV testing: rapid testing and detection of acute HIV infection. In this article, we review the public health goals of rapid HIV testing and acute HIV testing and explore how rapid tests to directly detect HIV antigens or nucleic acids might alter current approaches to HIV case identification in clinical and public health screening settings. We discuss the specific types of HIV screening programs and settings in which direct viral rapid testing would offer an important advantage. Finally, we suggest priorities in operations research that must be achieved to pave the way for the future introduction of direct rapid viral testing technologies in the HIV testing marketplace.

Indexed as

DNA, ViralHIVHIV Core Protein p24HIV InfectionsHumansImmunoassayMolecular Diagnostic TechniquesNucleic Acid Amplification TechniquesRNA, ViralTime FactorsDNA, ViralHIV Core Protein p24RNA, Viral

Identifiers

PMID20225950
OpenAlexW2109634151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.